Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
5.50
-0.09 (-1.61%)
At close: Jan 26, 2026, 4:00 PM EST
5.53
+0.03 (0.50%)
After-hours: Jan 26, 2026, 7:59 PM EST
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $1.89 billion as of January 26, 2026. Its market cap has increased by 72.38% in one year.
Market Cap
1.89B
Enterprise Value
1.40B
1-Year Change
72.38%
Ranking
Category
Stock Price
$5.50
Market Cap Chart
Since August 26, 2020, Nuvation Bio's market cap has increased from $174.48M to $1.89B, an increase of 980.70%. That is a compound annual growth rate of 55.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 1.92B | -37.61% |
| Dec 31, 2025 | 3.07B | 243.11% |
| Dec 31, 2024 | 895.27M | 170.80% |
| Dec 29, 2023 | 330.61M | -21.16% |
| Dec 30, 2022 | 419.31M | -77.35% |
| Dec 31, 2021 | 1.85B | 779.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zai Lab | 2.04B |
| Olema Pharmaceuticals | 1.98B |
| Aurinia Pharmaceuticals | 1.92B |
| Vericel | 1.91B |
| Sionna Therapeutics | 1.89B |
| Ardelyx | 1.89B |
| Nurix Therapeutics | 1.88B |
| Pharvaris | 1.82B |